RAPS is closely monitoring developments in the Coronavirus (COVID-19) outbreak. See our public safety page for the latest updates.

  • Regulatory NewsRegulatory News

    Government Report Slams DEA for Oversight of Drug Production Quota System

    Shortages of some pharmaceutical products could be alleviated if the Drug Enforcement Administration (DEA) coordinated its efforts to control the supply of some drugs more closely with the US Food and Drug Administration (FDA), a new government report has found. Background In the US, drug products are primarily overseen by two federal agencies: FDA and DEA. The former regulates drugs in accordance with their efficacy, safety and quality. For example, FDA might approve a...
  • Regulatory NewsRegulatory News

    DEA to Increase Marijuana Production Quota to Meet Demand of Medical Researchers

    The US Drug Enforcement Administration (DEA) is proposing to more than triple the amount of marijuana it will allow to be produced this year in the hopes of meeting the demand of researchers studying new medicinal uses for the drug, it has announced. Background In the US, the manufacture and production of marijuana is controlled by the DEA, whose authority to do so stems from the Controlled Substances Act (CSA) —a law which categorizes drugs in accordance with their ri...
  • DEA to Increase Supply of ADHD, Opioid Ingredients in Light of Shortages

    • 06 July 2012
    The US agency in charge of setting drug production quotas for substances regulated under the Controlled Substances Act (CSA) is proposing a mid-year adjustment in its production quotas for the active pharmaceutical ingredients contained within many attention deficit hyperactive disorder (ADHD) drugs and painkillers in response to growing drug shortages. In a 5 July 2012 Federal Register posting, the US Drug Enforcement Administration (DEA) announced it is looking to ...